Search Results

You searched for : Janssen

	Wysa's mental health platform raises $20 million Mental health disorders are faced by a wide range of populations across India. But people continue to suffer due to stigma and a lack of ... Jul 15
	HealthQuad Fund-II round closes at $162 million Healthcare venture capital HealthQuad has announced the closing of its second fund round at $162 million.... Apr 01
	Remix Therapeutics enters collaboration with Janssen to advance small molecule therapeutics Latest pharma news update... Feb 21
	Reduced Risk of Long Covid Infection After Vaccination Let us know who has reduced the risk of infection after covid vaccination- Elderly V/s Middle-aged group V/s Young children. Let us ... Feb 18
	Two dose version of Johnson & Johnson shot 94% effective against Covid-19, study finds Johnson and Johnson vaccine news... Sep 22
	Moderna's vaccine is the most effective, but Pfizer and J&J also protect well, CDC Latest pharma news update... Sep 20
	Johnson & Johnson booster shot prompts large increase in immune response, company says Latest Pharma news update... Aug 26
	J&J Covid-19 vaccine lasts at least 8 months, protects against Delta variant, studies find J&J Vaccine gets emergency FDA approval... Jul 06
	Risk of dying from Covid-19 40 times the risk of rare blood clot after receiving J&J vaccine A blood clot is less risky than Covid says CDC... May 13
	WHO authorizes China's Sinopharm Covid-19 vaccine for emergency use Sinopharm is the sixth vaccine to get WHO approval... May 08
	FDA and CDC lift recommend â€œPauseâ€ on Johnson & Johnson Janssen COVID 19 vaccine Safety is a top priority when it comes to vaccines. The pause was an example of extensive safety monitoring for the people and to ensure ... Apr 27
	CDC, FDA deregulates Johnson & Johnson covid vaccine with blood clot warning US lifts ban on the J&J vaccine with a warning on the bottle... Apr 26
	US COVID News Update: Approximately 212 million Covid-19 vaccine doses have been administered in the US About 40% of the US population, more than 132 million people, have received at least one dose of vaccine... Apr 20
	Johnson & Johnson's Covid-19 vaccine gets emergency use authorization from FDA Johnson's vaccine is indicated for individuals above 18 years... Mar 01
	Janssen received U.S. FDA approval for DARZALEX FASPRO Genmab announces that Janssen has been Granted U.S. FDA Approval for DARZALEX FASPRO (daratumumab and hyaluronidase-fihj) for Patients with Newly Diagnosed Light-chain (... Jan 16
	Johnson and Johnson vaccine trial shows immune response with few side effects FDA says J&J vaccine seems to be effective against covid... Jan 14
	ViiV Healthcare announces the Marketing Authorisation of the first complete long-acting injectable HIV treatment in Europe This authorization represents the first time people living with HIV in Europe may be able to receive a long-acting injectable treatment that removes the ... Dec 21
	COVAX Announces additional deals to access promising COVID-19 vaccine candidates; plans global rollout starting Q1 2021 COVAX, today announced that it had arrangements in place to access nearly two billion doses of COVID-19 vaccine candidates, on behalf of 190 participating ... Dec 19
	COVAX announces additional deals to access promising COVID-19 vaccine candidates COVAX has guaranteed access to a portion of the first wave of production, followed by volume scales as further supply becomes available... Dec 19
	Strides Pharma receives USFDA approval for Oxybutynin Chloride Tablets The medication is used to treat overactive bladder and urinary conditions... Dec 18
	Johnson & Johnson initiates second global Phase 3 clinical trial of its Janssen COVID-19 vaccine candidate Janssen will aim to enroll participants in Belgium, Colombia, France, Germany, the Philippines, South Africa, Spain, the United Kingdom and the United States... Nov 30
	Insilico announces a multi-target AI-powered drug discovery collaboration with Janssen Since 2015 Insilico Medicine pioneered the field of generative adversarial networks and reinforcement learning for generative chemistry and generative biology... Nov 10
	Tempus announces strategic collaboration with Janssen This collaboration will help both the companies utilize their respective strengths to improve patient care... Nov 03
	Janssen submits new drug application to U.S. FDA for treatment of schizophrenia in adults ... Nov 02
	Janssen submits new drug application to U.S. FDA for treatment of schizophrenia in adults ... Nov 02
25 Matching result(s) found!

-Advertisements-

Trending Now
	Under 15 Children Under Threat: The TB Comeback No One Saw Coming April 04, 2025
	MGM Healthcare Performs World's First Modified Multi-Visceral Transplant for Rare Intestinal DisorderApril 04, 2025
	World Health Day 2025: St. George’s University’s Role in Preparing Doctors to Tackle Global Health ChallengesApril 04, 2025
	Strength Doesn’t Retire: The Science Behind Ageless PowerApril 04, 2025
	Beyond the Baby Bump: Can Delayed Pregnancy Increase Autism Risk in ChildrenApril 04, 2025
	University of Manchester invites applications for MA Social AnthropologyApril 03, 2025
	Ahead of World Health Day, Sova Health Launches Advanced Microbiome Tests & Evidence-Based Precision Supplements April 03, 2025
	Half of women cannot make decisions about their reproductive health and bodily autonomyApril 03, 2025
	UGRO CAPITAL LIMITED PUBLIC ISSUE OF SECURED, RATED, LISTED, REDEEMABLE, NON-CONVERTIBLE DEBENTURES (SECURED NCDS) OPENS TODAY EFFECTIVE ANNUALIZED YIELD UP TO 11.01% PER ANNUM* April 03, 2025
	SF Airlines Entrusts Çelebi India with Freighter Handling at Kempegowda International Airport, BengaluruApril 03, 2025
	Is This the Future of Physiotherapy? Inside Stance Health’s $1M ExpansionApril 03, 2025
	The Daily Shower Debate: Are You Washing Away Your Skin’s Health?April 03, 2025
	The Digital Sleep Thief: How Night-time Screen Addiction is Robbing You of Bed-time RestApril 02, 2025
	KKR Launches ‘Knight Bite’ – A Digital Series That Serves Up Food, Fun, and Cricket!April 02, 2025
	Crompton rolls out its all new range of Aura, Avancer & Jedi Air Coolers for an effortless summer cooling experienceApril 02, 2025
	CARE Hospitals, Hi-Tech City Strengthens Orthopaedics Department with Renowned SurgeonsApril 02, 2025
	World Autism Awareness Day: Breaking the Chains of Stigma in IndiaApril 02, 2025
	From Scroll to Squint: How Reels Are Reshaping Your VisionApril 02, 2025
	Moscow Center for Diagnostics and Telemedicine Receives License for Radiology Residency ProgramApril 02, 2025
	CARE Hospitals Launches AI-Powered Non-Invasive Therapy – An innovative modality introduced in Telangana & Andhra PradeshApril 02, 2025

Search Results

Wysa's mental health platform raises $20 million

HealthQuad Fund-II round closes at $162 million

Remix Therapeutics enters collaboration with Janssen to advance small molecule therapeutics

Reduced Risk of Long Covid Infection After Vaccination

Two dose version of Johnson & Johnson shot 94% effective against Covid-19, study finds

Moderna's vaccine is the most effective, but Pfizer and J&J also protect well, CDC

Johnson & Johnson booster shot prompts large increase in immune response, company says

J&J Covid-19 vaccine lasts at least 8 months, protects against Delta variant, studies find

Risk of dying from Covid-19 40 times the risk of rare blood clot after receiving J&J vaccine

WHO authorizes China's Sinopharm Covid-19 vaccine for emergency use

FDA and CDC lift recommend â€œPauseâ€ on Johnson & Johnson Janssen COVID 19 vaccine

CDC, FDA deregulates Johnson & Johnson covid vaccine with blood clot warning

US COVID News Update: Approximately 212 million Covid-19 vaccine doses have been administered in the US

Johnson & Johnson's Covid-19 vaccine gets emergency use authorization from FDA

Janssen received U.S. FDA approval for DARZALEX FASPRO

Johnson and Johnson vaccine trial shows immune response with few side effects

ViiV Healthcare announces the Marketing Authorisation of the first complete long-acting injectable HIV treatment in Europe

COVAX Announces additional deals to access promising COVID-19 vaccine candidates; plans global rollout starting Q1 2021

COVAX announces additional deals to access promising COVID-19 vaccine candidates

Strides Pharma receives USFDA approval for Oxybutynin Chloride Tablets

Johnson & Johnson initiates second global Phase 3 clinical trial of its Janssen COVID-19 vaccine candidate

Insilico announces a multi-target AI-powered drug discovery collaboration with Janssen

Tempus announces strategic collaboration with Janssen

Janssen submits new drug application to U.S. FDA for treatment of schizophrenia in adults

Janssen submits new drug application to U.S. FDA for treatment of schizophrenia in adults

Trending Now

FDA and CDC lift recommend â€œPauseâ€ on Johnson & Johnson Janssen COVID 19 vaccine